INTERCEPT PHARMACEUTICALS, INC. Annual Revenue from Contract with Customer, Excluding Assessed Tax in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2016 to 2022.
  • Intercept Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2023 was $88.8M, a 14.4% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending September 30, 2023 was $318M, a 14.6% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $286M, a 9.57% increase from 2021.
  • Intercept Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $261M, a 11.4% increase from 2020.
  • Intercept Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $234M, a 7.16% decline from 2019.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $286M +$25M +9.57% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $261M +$26.8M +11.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $234M -$18M -7.16% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $252M +$72.2M +40.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $180M +$48.8M +37.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $131M +$106M +425% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $25M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.